Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Belle Health vs RedBox Rx

Belle Health
Graded #48

Higher grade

vs+6.599999999999994
RedBox Rx
Graded #111

Lower grade

The verdict

Belle Health takes it — 76.8/100 to 70.2/100.

Belle Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Belle Health is a national DTC telehealth platform offering compounded semaglutide and tirzepatide with flat-rate pricing — the same monthly cost at every dose, with no escalation surcharge as you titrate up.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBelle Health +49
91
42
Dose & formulationRedBox Rx +11
72
83
Clinical oversightRedBox Rx +22
71
93
Labs & monitoringRedBox Rx +12
72
84
FulfillmentBelle Health +13
85
72
Contract termsBelle Health +14
55
41
Belle Health · left barRedBox Rx · right bar

The numbers

MetricBelle HealthRedBox Rx
WeighScore76.8/10070.2/100
GradeCC
Scorecard rank#48#111
Semaglutide$119/mo$269/mo (all doses, 6-month plan, compounded)
Tirzepatide$199/mo (all doses, 3-month plan, compounded)$429/mo
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Belle Health

Graded #48 · C

Strengths

  • Five named compounding pharmacy partners disclosed (Striker, Strive, OptioRx, Enovex, Braun PharmaCare)
  • Flat-rate pricing — $119/mo semaglutide, $199/mo tirzepatide — doesn't rise at higher doses
  • Free weekly registered-dietitian sessions included
  • Operating since 2017
  • LegitScript Certified

Where it loses points

  • $199 tirzepatide price requires a 3-month bundle commitment
  • Compounded medications are not FDA-approved
  • Multi-pharmacy model — formulations may differ across orders
  • FDA issued this company a warning letter dated 20 February 2026; the letter is public in FDA's warning-letter database
RedBox Rx

Graded #111 · C

Strengths

  • Flat, dose-independent pricing on both semaglutide and tirzepatide
  • Offers both weekly injections and daily oral tablets
  • Includes unlimited provider follow-ups, a metabolic panel and a dietitian session
  • Backed by grocery-pharmacy parent company Hy-Vee

Where it loses points

  • Does not serve every state (for example Mississippi is excluded)
  • Does not publicly name its compounding pharmacy

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard